Sonoma Pharmaceuticals (SNOA) Depreciation & Amortization (CF) (2010 - 2025)

Sonoma Pharmaceuticals' Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $34000.0 for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) rose 3.03% year-over-year to $34000.0; the TTM figure through Dec 2025 stood at $137000.0 (down 7.43% YoY), while the FY2025 annual figure was $138000.0, down 21.59% from the prior year.
• Depreciation & Amortization (CF) was $34000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from $36000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $52000.0 in Q3 2021 to a low of $28000.0 in Q3 2022.
• Historically, Depreciation & Amortization (CF) has averaged $38550.0 across 5 years, with a median of $36500.0 in 2021.
• The sharpest annual moves came in 2021 and 2023: Depreciation & Amortization (CF) sank 60.0% in 2021, then surged 60.71% in 2023.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $37000.0 in 2021, then decreased by 13.51% to $32000.0 in 2022, then jumped by 40.62% to $45000.0 in 2023, then retreated by 26.67% to $33000.0 in 2024, then advanced by 3.03% to $34000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $34000.0 (Q4 2025), $36000.0 (Q3 2025), and $36000.0 (Q2 2025), per Business Quant data.